Published in Cancer Weekly, December 21st, 2004
The first tool helps clinicians analyze and identify a patient's hereditary risk of contracting breast and ovarian cancers, compares this risk with established national averages, and provides graphical representation to assist doctors in their explanation to the patient. The second tool will give an indication to community nurses in the field as to whether a full genetic analysis should be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.